Citenazone

This classification denotes an antiviral agent with the molecular formula C7H6N4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34RU0N173Q, chemically known as 2-thiophenecarbonitrile, 5-formyl-, thiosemicarbazone but generally known as citenazone, which bears US NIH Compound Identifier 3033956. European Medicines Agency schedules Citenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07488MIG. The term CITENAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). CITENAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule citenazone under HS 29349990 and SITC 51579. As of Q4 2014, CITENAZONE remains the US FDA Preferred Term for this commodity. Citenazone bears US NLM identifiers UMLS ID C0602975 and NCI Concept Code C87472. SMILES: S1C(CCC1C#N)/C=N/NC(=S)N.